• Chapter 30 - Two minutes to midnight: Critical overview of hemoptysis

  • May 1 2024
  • Durée: 1 h et 10 min
  • Podcast
Page de couverture de Chapter 30 - Two minutes to midnight: Critical overview of hemoptysis

Chapter 30 - Two minutes to midnight: Critical overview of hemoptysis

  • Résumé

  • Dr. Dagny Anderson, a specialist in the division of pulmonary and critical care medicine at Mayo Clinic, joins Alex and Venk to talk about both life threatening hemoptysis and non-lifethreatening hemoptysis. In this chapter we review what we need to be doing in the emergency department, while also shedding light on what our teammates in other specialties can offer the patients downstream. Join for this colorful journey of how to manage the situation when no one likes what is coming out of the patient's mouth.

    CONTACTS

    X - @AlwaysOnEM; @VenkBellamkonda

    YouTube - @AlwaysOnEM; @VenkBellamkonda

    Instagram – @AlwaysOnEM; @Venk_like_vancomycin; @ASFinch

    Email - AlwaysOnEM@gmail.com

    REFERENCES

    • Gopinath B, et al. Nebulized vs IV Tranexamic Acid for Hemoptysis - A pilot randomized controlled trial. Chest 2023;163(5):1176-1184
    • Wand O, Guber E, Guber A, Epstein Schochet G, Israeli-Shani L, Shitrit D. Inhaled Tranexamic Acid for Hempotysis Treatment: A randomized controlled trial. Chest 2018;154(6):1379
    • Ibrahim WH. Massive Hemoptysis:The definition should be revised. Eur Respir J. 2008 Oct;32(4):1131-2
    Voir plus Voir moins

Ce que les auditeurs disent de Chapter 30 - Two minutes to midnight: Critical overview of hemoptysis

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.